Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Possibility Of Viagra Switch Stirs AIDS Healthcare Group Into Action

This article was originally published in The Tan Sheet

Executive Summary

Even before Pfizer actually asks FDA to move Viagra from Rx to OTC status, the AIDS Healthcare Foundation says it will petition FDA to reject the drug maker's possible switch application for the erectile dysfunction drug

You may also be interested in...



Pfizer Pulls Back On European Viagra Switch As Questions Linger

Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20

Pfizer Pulls Back On European Viagra Switch As Questions Linger

Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20

Pfizer Pulls Back On European Viagra Switch As Questions Linger

Pfizer withdraws its application to switch Viagra 50 mg from prescription to nonprescription status through the European Medicines Agency's centralized process, the company said Nov. 20

Related Content

Topics

UsernamePublicRestriction

Register

PS100233

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel